Previous studies have reported on the association between the polymorphism in the () gene and opioid use disorder (OUD) with inconsistent outcomes. The goal of this study was to examine the correlation of the polymorphism and OUD using a meta-analysis approach. Six electronic databases, including PubMed, Web of Science, Cochrane Library, EMBASE, Wanfang and CNKI, were searched thoroughly for relevant studies on the association of the polymorphism and OUD up to September, 2021.
View Article and Find Full Text PDFBackground: Prodynorphin (PDYN) gene polymorphisms have been linked with opioid dependence (OD) with conflicting outcomes, the aim of this study is to synthesize the existing evidence of the association between PDYN polymorphisms and OD susceptibility.
Methods: Four databases including PubMed, EMBASE, Web of Science, and Wanfang were retrieved for relevant studies before August, 2018. All identified studies were evaluated using predetermined inclusion and exclusion criteria.